Cargando…

A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma

Renal cell carcinoma is one of the most common tumors in the urinary system, among which clear cell renal cell carcinoma is the most common subtype with poor prognosis. As one of the tumors closely related to lipid metabolism, the role of fatty acid metabolism in ccRCC was investigated to predict th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Zhihao, Cheng, Gong, Ye, Yuzhong, Le, Changjie, Miao, Qi, Chen, Jiawei, Yang, Hongmei, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304894/ https://www.ncbi.nlm.nih.gov/pubmed/35873479 http://dx.doi.org/10.3389/fgene.2022.894736

Ejemplares similares

Novel amino acid metabolism‐related gene signature to predict prognosis in clear cell renal cell carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2022)

Identification of subtypes of clear cell renal cell carcinoma and construction of a prognostic model based on fatty acid metabolism genes
por: Nie, Shiwen, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma
por: Gao, Suhua, et al.
Publicado: (2021)

The Clinical Significance of DNA Damage Repair Signatures in Clear Cell Renal Cell Carcinoma
por: Guo, Ergang, et al.
Publicado: (2021)

An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
por: Li, Jiaying, et al.
Publicado: (2022)

METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022)

Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Lu, Junwan, et al.
Publicado: (2021)

Identification of a Five-miRNA Signature for Diagnosis of Kidney Renal Clear Cell Carcinoma
por: Zhao, Enyang, et al.
Publicado: (2022)

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma
por: Yu, Qingxin, et al.
Publicado: (2022)

Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2021)

A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
por: Zhou, Tao, et al.
Publicado: (2022)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)

NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
por: Chen, Jiasheng, et al.
Publicado: (2022)

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
por: Tan, Diaoyi, et al.
Publicado: (2023)

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Ren, Xueting, et al.
Publicado: (2021)

Construction of a novel prognostic signature based on the composition of tumor-infiltrating immune cells in clear cell renal cell carcinoma
por: Yu, Weiwei, et al.
Publicado: (2022)

Fatty acid metabolism-related signature predicts survival in patients with clear cell renal carcinoma
por: Wang, Rongjiang, et al.
Publicado: (2022)

Identification of a Novel Signature and Construction of a Nomogram Predicting Overall Survival in Clear Cell Renal Cell Carcinoma
por: Wu, Xiangkun, et al.
Publicado: (2020)

Generation and Analysis of Pyroptosis-Based and Immune-Based Signatures for Kidney Renal Clear Cell Carcinoma Patients, and Cell Experiment
por: Lin, Gaoteng, et al.
Publicado: (2022)

A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints
por: Dong, Yunze, et al.
Publicado: (2022)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022)

Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
por: Yao, Zhi-Yong, et al.
Publicado: (2021)

Identification of Novel Glycolysis-Related Gene Signatures Associated With Prognosis of Patients With Clear Cell Renal Cell Carcinoma Based on TCGA
por: Wu, Chengjiang, et al.
Publicado: (2020)

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma
por: Chen, Zhuo, et al.
Publicado: (2022)

A Potential Fatty Acid Metabolism-Related Gene Signature for Prognosis in Clear Cell Renal Cell Carcinoma
por: Zhang, He, et al.
Publicado: (2022)

Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma
por: Zuo, You, et al.
Publicado: (2022)

Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Identification of a Novel Epigenetic Signature CHFR as a Potential Prognostic Gene Involved in Metastatic Clear Cell Renal Cell Carcinoma
por: Chen, Xiangling, et al.
Publicado: (2021)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2021)

A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients
por: Shen, Cheng, et al.
Publicado: (2022)

A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
por: Mei, Wangli, et al.
Publicado: (2022)

Construction of a fatty acid metabolism-related gene signature for predicting prognosis and immune response in breast cancer
por: Qian, Li, et al.
Publicado: (2023)

Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model
por: Qu, GenYi, et al.
Publicado: (2023)

Expression of AOX1 Predicts Prognosis of Clear Cell Renal Cell Carcinoma
por: Xiong, Luyang, et al.
Publicado: (2021)

Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer
por: Miao, Qi, et al.
Publicado: (2023)

Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma
por: Hong, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pbb5kkmkpmhc8k2366q8upmjji